Emerging Role of Interleukins in Cancer TreatmentGhazaleh Shoja E Razavi1* and Timothy Allen2
- *Corresponding Author:
- Ghazaleh Shoja E Razavi
Department of Clinical
Development-Oncology and Respiratory
Global Allied Pharmaceutical
Florida 32779, USA
Tel: 1- 416-520-8835
E-mail: [email protected]
Received date: March 10, 2015; Accepted date: June 06, 2015; Published date: June 11, 2015
Citation: Razavi GSE, Allen T (2015) Emerging Role of Interleukins in Cancer Treatment. Immunome Res S2:006. doi:10.4172/1745-7580.S2.006
Copyright: ©2015 Razavi GSE, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Interleukins as a part of immune system were first represented in 1977. However, advancing knowledge of
immune system and its role in pathogenesis of different diseases from allergic reactions to autoimmune disorders and even cancer makes these immune mediators an attractive target among different available treatment modalities. This article discusses the role of interleukins in cancer treatment.